return to news
  1. Paras Healthcare shares debut at 4% premium on NSE, BSE; here's how much investors made per lot

Market News

Paras Healthcare shares debut at 4% premium on NSE, BSE; here's how much investors made per lot

Journalist Kamal Joshi, former Republic TV and latestly news editor, currently associated with Upstox as senior ipo writer.

2 min read | Updated on October 28, 2026, 10:31 IST

SUMMARY

The ₹1,450 crore Paras Healthcare IPO was a combination of a fresh issuance of shares worth ₹500 crore and an offer-for-sale (OFS) component of shares totalling ₹950 crore by promoter Dharminder Kumar Nagar and investor Commelina Ltd.

Paras Healthcare Ltd is a leading clinical specialty-led hospital platform. | Parashospitals.com

Paras Healthcare Ltd is a leading clinical specialty-led hospital platform. | Parashospitals.com

Shares of Paras Healthcare debuted at ₹720 apiece on the National Stock Exchange (NSE) and the BSE on Wednesday, October 28.

This reflects a premium of 3.90% the IPO issue price of ₹693 per share.

Paras Healthcare share price: Here's how much investors made per lot

A lot consisted of 21 shares and cost ₹14,553. Investors who received Paras Healthcare IPO allotment made ₹567 per lot, taking the value of their investment to ₹15,120, as per the listing price on the NSE.

Open FREE Demat Account within minutes!
Join now

The ₹1,450 crore IPO was a combination of a fresh issuance of shares worth ₹500 crore and an offer-for-sale (OFS) component of shares totalling ₹950 crore by promoter Dharminder Kumar Nagar and investor Commelina Ltd.

Jio Platforms IPO Listing Live Updates: Check Key Developments Here

The net proceeds will be used to repay borrowing and for general corporate purposes.

"Our company expects to receive the benefits of listing its equity shares on the Stock Exchanges, including enhancing its visibility and brand image, and creating a public market for our equity shares," the firm said in its red herring prospectus.

The initial public offering was subscribed 2.23 times. It secured bids for 2,69,43,714 shares against 1,20,83,331 shares on offer, as per the data on the NSE website.

The retail portion was subscribed 2 times, while the category for qualified institutional buyers (QIBs) was booked 3.09 times. The part for non-institutional investors (NIIs) fetched 66% subscription.

Before the IPO, the company secured ₹652.5 crore from anchor investors, including SBI Mutual Fund, HDFC MF, Whiteoak Capital MF, Abu Dhabi Investment Authority, Eastspring Investments and BlackRock, among others.

The Gurugram-based firm operates eight hospitals across five states and one Union Territory. It specialises in cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics & sports injury, and renal sciences (CONGOR specialities).

JM Financial, Nuvama Wealth Management and BofA Securities India were the issue's book-running lead managers. while MUFG Intime India serves as the registrar.

Disclaimer: This article is written purely for informational purposes and should not be considered investment advice from Upstox. Securities mentioned are illustrative and not recommendations. Please consult a financial advisor before making any investment decisions.

About The Author

Journalist Kamal Joshi, former Republic TV and latestly news editor, currently associated with Upstox as senior ipo writer.
Kamal Joshi is a business journalist who covers markets and IPOs. He places a special focus on in-depth analysis of DRHPs, RHPs and public-issue documents to produce data-driven stories. He covers trends across mainboard and SME IPOs, anchor allocations, subscription status and post-listing performance. He is passionate about breaking news and enjoys playing pickleball, especially flexing his net play. He was previously associated with Republic TV and LatestLY.

Next Story

End of additional stories